Mithra, the Liège company that specialises in women's health, is targeting the South Korean market, having just signed an exclusive licence with Hyundai Pharm to market Estelle®.
Hyundai Pharm, a Korean company also specialising in women's health, is looking to further strengthen its growing presence in this sector. The South Korean contraceptive market is worth around 36 million euros a year.
The company, based in Seoul, is already the leading manufacturer and distributor of pharmaceutical products, diet foods and drinks and medical equipment. This agreement, signed in June 2018, indicates that it is preparing to make significant investments in the marketing of Estelle®, and demonstrates a clear desire to expand a South Korean contraception market that is still relatively weak, based on the innovative contraception produced by Mithra, whose expertise and reputation are well established !
Copyright logo & photo: https://www.mithra.com/
